Skip to main content
Signal8

Clever Leaves Holdings Inc. (CLVR)

Sector: Drug Manufacturers - Specialty & Generic

Industry: Drug Manufacturers - Specialty & Generic

Clever Leaves Holdings Inc. logo

Clever Leaves Holdings Inc.

OTC:CLVRHealthcare
CLOSED
Mkt Cap$2K
EV-
Float1.43M
O/S1.75M
VOL116 sh
RVOL0.52×
Inst Own-
SI0.5%
Net Cash/Sh-
Dilution
Historical Data
DateOpenHighLowCloseVolume
Nov 12, 20260.00000.00000.00000.0000116
Nov 5, 20260.00100.00100.00100.0010333
Oct 13, 20260.01120.01120.01120.0112610
Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
Not available
Ratings Distribution
BUY
1
HOLD
1
SELL
0
TOTAL2
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
--
Institutional
(0)
--
Insiderⓘ
(0)
--
5%+ Owners
(1)
--
Unattributed (incl. retail)ⓘ
Top Shareholders
NameShares%
BCM Investimentos Fundo de Investimento Multimercado Crédito Privado Investimento no Exterior logo
BCM Investimentos Fundo de Investimento Multimercado Crédito Privado Investimento no Exterior
· may incl. warrants· stale · filed May 2024
322.2K18.4%
Sources: 13D/13G
About

Clever Leaves Holdings Inc. is a company primarily focused on the cannabis sector.

Its operations are structured into two distinct divisions: Cannabinoid and Non-Cannabinoid. The Cannabinoid segment oversees the global cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid-based products. In contrast, the Non-Cannabinoid segment, operating within the United States, specializes in the formulation, production, marketing, sales, and delivery of a diverse array of nutraceuticals, natural remedies, wellness items, detoxification solutions, and various nutritional and dietary supplements. These products are supplied to a broad clientele, including mass retailers, specialized health stores, and distributors.

The company was founded in 2017 and is headquartered in Boca Raton, Florida.

Key Metrics
Market Cap$1,755
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership-

No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ExchangeOTC
CountryUSUS
IPO DateDec 18, 2020
Shares Outstanding1.75M
Authorized Shares
Float1.43M
52-Week Range
Volume
Average Daily Volume225

30d Avg

225

60d Avg

404

90d Avg

407

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...